Stocks Health care ETON
NASDAQ · Health careEton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. brought in $105.6M of revenue over the twelve months to June 30, 2026, up 81.5% from a year earlier. Net income was $12.7M, a net margin of 12.0%. Operating cash flow minus capital spending left $10.2M of free cash flow in fiscal 2025. At June 30, 2026 it held $26.8M in cash against $19.1M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Eton Pharmaceuticals, Inc. does
Eton Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker ETON.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $80M | -$4.6M | -$0.17 | $10.2M |
| 2024 | $39M | -$3.8M | -$0.15 | $943K |
| 2023 | $31.6M | -$936K | -$0.04 | $6.8M |
| 2022 | $21.3M | -$9M | -$0.36 | $4.8M |
| 2021 | $21.8M | -$2M | -$0.08 | -$4.7M |
| 2020 | $39K | -$28M | -$1.33 | -$22.4M |
Latest SEC filings
What Eton Pharmaceuticals, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- August 13, 2026
- August 5, 2026
- August 4, 2026
- July 29, 2026Other event 8-K
- July 28, 2026Passive stake changed SCHEDULE 13G/A
- June 9, 2026
- May 19, 2026
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026
- May 14, 2026
Questions about ETON
What does Eton Pharmaceuticals, Inc. do?
Eton Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker ETON.
Is Eton Pharmaceuticals, Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $12.7M on revenue of $105.6M, a net margin of 12.0%.
How much revenue does Eton Pharmaceuticals, Inc. make?
Over the twelve months to June 30, 2026 Eton Pharmaceuticals, Inc. reported revenue of $105.6M. That is 81.5% more than a year earlier.
When did Eton Pharmaceuticals, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade (amended) from August 31, 2026.
Similar companies
Follow ETON
Get an email when Eton Pharmaceuticals, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow ETON: get an email when it filesWhere the numbers come from
Financial figures are the values Eton Pharmaceuticals, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.